Ampio Pharmaceuticals
AMPE
#10731
Rank
NZ$0.3 M
Marketcap
NZ$0.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): NZ-$28.89

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$29.84. In 2022 the company made an earnings per share (EPS) of NZ-$37.96 an increase over its 2021 EPS that were of NZ-$47.27.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$28.89-23.9%
2022NZ-$37.96-19.7%
2021NZ-$47.27-0%
2020NZ-$47.27-10%
2019NZ-$52.53-121.74%
2018NZ$241.62-158.23%
2017NZ-$414.96119.44%
2016NZ-$189.10-41.94%
2015NZ-$325.67-18.42%
2014NZ-$399.2120.63%
2013NZ-$330.9285.29%
2012NZ-$178.59-52.11%
2011NZ-$372.9444.9%
2010NZ-$257.38390%
2009NZ-$52.53233.33%
2008NZ-$15.76-0%
2007NZ-$15.76
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.50-165.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.38-107.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.57-122.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$75.50-353.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
NZ$11.08-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.31-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA